\n<\/p>\n
European stocks were flat to slightly lower on Tuesday and the U.S. dollar slipped to an over two-month low ahead of the start of a two-day policy meeting of the Federal Reserve later in the day, with traders eyeing a widely expected 25 bps rate cut. <\/p>\n
In economic releases, the U.K. jobless rate remained unchanged and average earnings growth slowed in the three months to July, the Office for National Statistics said.<\/p>\n
The unemployment rate was at 4.7 percent in the three months to July, unchanged from the previous period. <\/p>\n
Average earnings excluding bonuses increased 4.8 percent in May to July, which was down from 5.0 percent in the previous three-month period and matched expectations.<\/p>\n
In August, payroll employment decreased 127,000 from the previous year and by 8,000 from the previous month to 30.3 million.<\/p>\n
Eurozone industrial production figures and the German ZEW economic sentiment survey results are awaited later in the day. <\/p>\n
The pan European STOXX 600 was marginally lower at 556.83 after rising 0.4 percent on Monday. <\/p>\n
The German DAX slipped 0.2 percent, France’s CAC 40 was marginally lower and the U.K.’s FTSE 100 edged down by 0.1 percent. <\/p>\n
Online review platform Trustpilot soared 8 percent in London after delivering both top-line growth and improved profitability in the first half of 2025 and launching a new share buyback program. <\/p>\n
Anglo American rose about 1 percent. The mining giant has signed a definitive agreement with Codelco to coordinate operations at Los Bronces and Andina in Chile.<\/p>\n
Hochschild Mining rose 1.2 percent as it announced the appointment of Cassio Diedrich as Chief Operating Officer.<\/p>\n
Hiring firm SThree plummeted 20 percent after forecasting annual pre-tax profit well below market expectations.<\/p>\n
FMCG major Unilever fell nearly 1 percent after announcing a new CFO.<\/p>\n
Basilea Pharmaceutica tallied 2.3 percent. The Swiss drug developer said it has received additional $25 million funding from BARDA for antifungal development. <\/p>\n<\/p>\n
Market Analysis<\/p>\n<\/div>\n